nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—CYP3A4—Methoxsalen—vitiligo	0.245	1	CbGbCtD
Trametinib—MAP2K2—Cellular roles of Anthrax toxin—NLRP1—vitiligo	0.0645	0.0902	CbGpPWpGaD
Trametinib—MAP2K1—Cellular roles of Anthrax toxin—NLRP1—vitiligo	0.0603	0.0843	CbGpPWpGaD
Trametinib—MAP2K2—PDGFR-beta signaling pathway—SLA—vitiligo	0.035	0.0489	CbGpPWpGaD
Trametinib—MAP2K1—PDGFR-beta signaling pathway—SLA—vitiligo	0.0327	0.0458	CbGpPWpGaD
Trametinib—MAP2K2—Signaling events mediated by Stem cell factor receptor (c-Kit)—MITF—vitiligo	0.0152	0.0213	CbGpPWpGaD
Trametinib—MAP2K1—Signaling events mediated by Stem cell factor receptor (c-Kit)—MITF—vitiligo	0.0143	0.0199	CbGpPWpGaD
Trametinib—MAP2K2—Signaling events mediated by Stem cell factor receptor (c-Kit)—SH2B3—vitiligo	0.0136	0.019	CbGpPWpGaD
Trametinib—MAP2K2—Kit receptor signaling pathway—MITF—vitiligo	0.0136	0.019	CbGpPWpGaD
Trametinib—MAP2K1—RANKL/RANK Signaling Pathway—MITF—vitiligo	0.0134	0.0188	CbGpPWpGaD
Trametinib—MAP2K2—IL-7 Signaling Pathway—IL2RA—vitiligo	0.0133	0.0186	CbGpPWpGaD
Trametinib—MAP2K1—Signaling events mediated by Stem cell factor receptor (c-Kit)—SH2B3—vitiligo	0.0127	0.0178	CbGpPWpGaD
Trametinib—MAP2K1—Kit receptor signaling pathway—MITF—vitiligo	0.0127	0.0177	CbGpPWpGaD
Trametinib—MAP2K1—IL-7 Signaling Pathway—IL2RA—vitiligo	0.0125	0.0174	CbGpPWpGaD
Trametinib—MAP2K2—Amyotrophic lateral sclerosis (ALS)—CAT—vitiligo	0.0113	0.0158	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signaling in naïve CD8+ T cells—GZMB—vitiligo	0.011	0.0154	CbGpPWpGaD
Trametinib—CYP3A4—Aflatoxin B1 metabolism—GSTM1—vitiligo	0.0104	0.0146	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signaling in naïve CD8+ T cells—GZMB—vitiligo	0.0103	0.0144	CbGpPWpGaD
Trametinib—MAP2K2—Oncostatin M Signaling Pathway—CASP7—vitiligo	0.0102	0.0142	CbGpPWpGaD
Trametinib—MAP2K1—Oncostatin M Signaling Pathway—CASP7—vitiligo	0.00952	0.0133	CbGpPWpGaD
Trametinib—Dermatitis acneiform—Methoxsalen—vitiligo	0.00885	0.285	CcSEcCtD
Trametinib—MAP2K2—IL-2 Signaling Pathway—IL2RA—vitiligo	0.00879	0.0123	CbGpPWpGaD
Trametinib—MAP2K2—TCR Signaling Pathway—SH2B3—vitiligo	0.00862	0.0121	CbGpPWpGaD
Trametinib—MAP2K1—IL-2 Signaling Pathway—IL2RA—vitiligo	0.00822	0.0115	CbGpPWpGaD
Trametinib—MAP2K1—TCR Signaling Pathway—SH2B3—vitiligo	0.00806	0.0113	CbGpPWpGaD
Trametinib—MAP2K2—TSLP Signaling Pathway—IL2RA—vitiligo	0.00803	0.0112	CbGpPWpGaD
Trametinib—MAP2K2—Interleukin-2 signaling—IL2RA—vitiligo	0.00803	0.0112	CbGpPWpGaD
Trametinib—MAP2K1—TSLP Signaling Pathway—IL2RA—vitiligo	0.00751	0.0105	CbGpPWpGaD
Trametinib—MAP2K1—Interleukin-2 signaling—IL2RA—vitiligo	0.00751	0.0105	CbGpPWpGaD
Trametinib—MAP2K2—IL2-mediated signaling events—IL2RA—vitiligo	0.00719	0.0101	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signaling in naïve CD8+ T cells—CD8A—vitiligo	0.00679	0.0095	CbGpPWpGaD
Trametinib—MAP2K2—SHP2 signaling—IL2RA—vitiligo	0.00679	0.00949	CbGpPWpGaD
Trametinib—MAP2K1—IL2-mediated signaling events—IL2RA—vitiligo	0.00672	0.0094	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signaling in naïve CD8+ T cells—CD8A—vitiligo	0.00635	0.00888	CbGpPWpGaD
Trametinib—MAP2K1—SHP2 signaling—IL2RA—vitiligo	0.00635	0.00888	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signaling in naïve CD8+ T cells—IL2RA—vitiligo	0.00612	0.00856	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by SCF-KIT—SH2B3—vitiligo	0.00602	0.00842	CbGpPWpGaD
Trametinib—MAP2K1—Senescence and Autophagy in Cancer—CD44—vitiligo	0.00578	0.00809	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signaling in naïve CD8+ T cells—IL2RA—vitiligo	0.00573	0.00801	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by SCF-KIT—SH2B3—vitiligo	0.00563	0.00787	CbGpPWpGaD
Trametinib—MAP2K2—TCR Signaling Pathway—CD8A—vitiligo	0.0053	0.00741	CbGpPWpGaD
Trametinib—MAP2K1—TCR Signaling Pathway—CD8A—vitiligo	0.00496	0.00693	CbGpPWpGaD
Trametinib—CYP3A4—Estrogen metabolism—GSTM1—vitiligo	0.00491	0.00686	CbGpPWpGaD
Trametinib—Folliculitis—Methoxsalen—vitiligo	0.00481	0.155	CcSEcCtD
Trametinib—MAP2K2—MAPK Signaling Pathway—CASP7—vitiligo	0.00476	0.00666	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—NLRP1—vitiligo	0.00472	0.00661	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—CASP7—vitiligo	0.00445	0.00623	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—NLRP1—vitiligo	0.00442	0.00618	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by Interleukins—IL2RA—vitiligo	0.00413	0.00577	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—CASP7—vitiligo	0.00402	0.00562	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by Interleukins—IL2RA—vitiligo	0.00386	0.0054	CbGpPWpGaD
Trametinib—MAP2K2—Toll-like Receptor Signaling Pathway—CD80—vitiligo	0.00361	0.00504	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—LRR1—vitiligo	0.00344	0.00481	CbGpPWpGaD
Trametinib—MAP2K1—Toll-like Receptor Signaling Pathway—CD80—vitiligo	0.00337	0.00472	CbGpPWpGaD
Trametinib—MAP2K1—neck—vitiligo	0.00326	0.379	CbGeAlD
Trametinib—MAP2K1—Immune System—LRR1—vitiligo	0.00322	0.0045	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—CD44—vitiligo	0.00282	0.00394	CbGpPWpGaD
Trametinib—MAP2K2—Regulation of toll-like receptor signaling pathway—CD80—vitiligo	0.00282	0.00394	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by SCF-KIT—CD80—vitiligo	0.00278	0.00389	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—NLRP1—vitiligo	0.00275	0.00385	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signaling of activated FGFR—CD80—vitiligo	0.00266	0.00372	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—CD44—vitiligo	0.00264	0.00369	CbGpPWpGaD
Trametinib—MAP2K1—Regulation of toll-like receptor signaling pathway—CD80—vitiligo	0.00263	0.00368	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB4—CD80—vitiligo	0.00262	0.00367	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—HERC2—vitiligo	0.00261	0.00365	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by SCF-KIT—CD80—vitiligo	0.0026	0.00364	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—NLRP1—vitiligo	0.00257	0.0036	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signal transduction—CD80—vitiligo	0.0025	0.0035	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signaling of activated FGFR—CD80—vitiligo	0.00249	0.00348	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR—CD80—vitiligo	0.00249	0.00348	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB2—CD80—vitiligo	0.00248	0.00347	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 signaling—CD80—vitiligo	0.00247	0.00345	CbGpPWpGaD
Trametinib—CYP3A4—Tryptophan metabolism—CAT—vitiligo	0.00245	0.00343	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB4—CD80—vitiligo	0.00245	0.00343	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HERC2—vitiligo	0.00244	0.00341	CbGpPWpGaD
Trametinib—CYP2C8—Biological oxidations—GSTT1—vitiligo	0.00236	0.0033	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signal transduction—CD80—vitiligo	0.00234	0.00327	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR—CD80—vitiligo	0.00233	0.00326	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR in disease—CD80—vitiligo	0.00232	0.00324	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—CD80—vitiligo	0.00232	0.00324	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—CD80—vitiligo	0.00232	0.00324	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—CD80—vitiligo	0.00232	0.00324	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 signaling—CD80—vitiligo	0.00231	0.00323	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR—CD80—vitiligo	0.0023	0.00322	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—CD80—vitiligo	0.00228	0.00319	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—CD80—vitiligo	0.00227	0.00317	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—CD80—vitiligo	0.00217	0.00304	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—CD80—vitiligo	0.00217	0.00304	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—CD80—vitiligo	0.00217	0.00304	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—CD80—vitiligo	0.00215	0.00301	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—CD80—vitiligo	0.00213	0.00298	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—CD80—vitiligo	0.00212	0.00297	CbGpPWpGaD
Trametinib—MAP2K1—skin of body—vitiligo	0.00211	0.246	CbGeAlD
Trametinib—MAP2K2—Innate Immune System—CCR6—vitiligo	0.00206	0.00288	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—IFIH1—vitiligo	0.00206	0.00288	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—CD80—vitiligo	0.00206	0.00287	CbGpPWpGaD
Trametinib—Dry skin—Methoxsalen—vitiligo	0.00201	0.0648	CcSEcCtD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—IL2RA—vitiligo	0.00193	0.00269	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—CCR6—vitiligo	0.00192	0.00269	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—IFIH1—vitiligo	0.00192	0.00269	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—CD80—vitiligo	0.00192	0.00269	CbGpPWpGaD
Trametinib—MAP2K2—skin of body—vitiligo	0.00186	0.216	CbGeAlD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—IL2RA—vitiligo	0.0018	0.00252	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—MC1R—vitiligo	0.00176	0.00245	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—MC1R—vitiligo	0.00164	0.0023	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—CD80—vitiligo	0.00158	0.00221	CbGpPWpGaD
Trametinib—CYP2C8—Biological oxidations—GSTM1—vitiligo	0.0015	0.0021	CbGpPWpGaD
Trametinib—CYP2C8—Metapathway biotransformation—GSTM1—vitiligo	0.00148	0.00207	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—CD80—vitiligo	0.00148	0.00207	CbGpPWpGaD
Trametinib—MAP2K2—thyroid gland—vitiligo	0.00137	0.159	CbGeAlD
Trametinib—Arrhythmia—Methoxsalen—vitiligo	0.00136	0.0437	CcSEcCtD
Trametinib—Erythema—Methoxsalen—vitiligo	0.00132	0.0426	CcSEcCtD
Trametinib—MAP2K2—Signaling by GPCR—CCR6—vitiligo	0.00131	0.00183	CbGpPWpGaD
Trametinib—Dysgeusia—Methoxsalen—vitiligo	0.00129	0.0417	CcSEcCtD
Trametinib—Muscle spasms—Methoxsalen—vitiligo	0.00127	0.041	CcSEcCtD
Trametinib—CYP3A4—Biological oxidations—GSTT1—vitiligo	0.00127	0.00177	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CCR6—vitiligo	0.00123	0.00172	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IFIH1—vitiligo	0.0012	0.00167	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CCR6—vitiligo	0.0012	0.00167	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CCR6—vitiligo	0.00112	0.00157	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IFIH1—vitiligo	0.00112	0.00157	CbGpPWpGaD
Trametinib—Oedema—Methoxsalen—vitiligo	0.00108	0.0348	CcSEcCtD
Trametinib—Infection—Methoxsalen—vitiligo	0.00107	0.0345	CcSEcCtD
Trametinib—Skin disorder—Methoxsalen—vitiligo	0.00105	0.0338	CcSEcCtD
Trametinib—MAP2K2—Signaling Pathways—MC1R—vitiligo	0.00104	0.00145	CbGpPWpGaD
Trametinib—Insomnia—Methoxsalen—vitiligo	0.000975	0.0314	CcSEcCtD
Trametinib—MAP2K1—Signaling Pathways—MC1R—vitiligo	0.00097	0.00136	CbGpPWpGaD
Trametinib—Gastrointestinal disorder—Methoxsalen—vitiligo	0.000931	0.03	CcSEcCtD
Trametinib—MAP2K2—Immune System—CD44—vitiligo	0.000921	0.00129	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CTLA4—vitiligo	0.000908	0.00127	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—CD80—vitiligo	0.000902	0.00126	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD44—vitiligo	0.000862	0.0012	CbGpPWpGaD
Trametinib—Body temperature increased—Methoxsalen—vitiligo	0.000852	0.0275	CcSEcCtD
Trametinib—MAP2K2—Disease—CD44—vitiligo	0.00085	0.00119	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CTLA4—vitiligo	0.000849	0.00119	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—CD80—vitiligo	0.000844	0.00118	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—GSTM1—vitiligo	0.000807	0.00113	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CD44—vitiligo	0.000796	0.00111	CbGpPWpGaD
Trametinib—CYP3A4—Metapathway biotransformation—GSTM1—vitiligo	0.000796	0.00111	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCR6—vitiligo	0.000774	0.00108	CbGpPWpGaD
Trametinib—Pruritus—Methoxsalen—vitiligo	0.000763	0.0246	CcSEcCtD
Trametinib—MAP2K2—Signaling Pathways—SH2B3—vitiligo	0.000734	0.00103	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—GZMB—vitiligo	0.00073	0.00102	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCR6—vitiligo	0.000725	0.00101	CbGpPWpGaD
Trametinib—Dizziness—Methoxsalen—vitiligo	0.000713	0.023	CcSEcCtD
Trametinib—MAP2K2—Immune System—CD8A—vitiligo	0.000698	0.000976	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—IL2RA—vitiligo	0.000689	0.000963	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—SH2B3—vitiligo	0.000687	0.00096	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—GZMB—vitiligo	0.000683	0.000954	CbGpPWpGaD
Trametinib—Rash—Methoxsalen—vitiligo	0.00068	0.0219	CcSEcCtD
Trametinib—Dermatitis—Methoxsalen—vitiligo	0.000679	0.0219	CcSEcCtD
Trametinib—Headache—Methoxsalen—vitiligo	0.000676	0.0218	CcSEcCtD
Trametinib—MAP2K1—Immune System—CD8A—vitiligo	0.000653	0.000913	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—IL2RA—vitiligo	0.000644	0.000901	CbGpPWpGaD
Trametinib—Nausea—Methoxsalen—vitiligo	0.000641	0.0206	CcSEcCtD
Trametinib—MAP2K2—Immune System—IL2RA—vitiligo	0.000629	0.00088	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL2RA—vitiligo	0.000589	0.000823	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CD80—vitiligo	0.000525	0.000734	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD80—vitiligo	0.000491	0.000687	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CD80—vitiligo	0.000485	0.000678	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CD80—vitiligo	0.000454	0.000634	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL2RA—vitiligo	0.000407	0.000569	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GSTT1—vitiligo	0.000403	0.000564	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL2RA—vitiligo	0.000381	0.000532	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CD80—vitiligo	0.00034	0.000475	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CD44—vitiligo	0.000335	0.000469	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CD80—vitiligo	0.000318	0.000444	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CAT—vitiligo	0.000272	0.000381	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GSTM1—vitiligo	0.000257	0.000359	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GSTT1—vitiligo	0.000217	0.000303	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CD44—vitiligo	0.00018	0.000252	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CAT—vitiligo	0.000146	0.000204	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GSTM1—vitiligo	0.000138	0.000193	CbGpPWpGaD
